[Federal Register Volume 76, Number 142 (Monday, July 25, 2011)]
[Notices]
[Pages 44338-44339]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2011-18755]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[Docket Number NIOSH-245]
Notice of Public Meeting on the NIOSH Document Titled: ``Criteria
for a Recommended Standard: Occupational Exposure to Diacetyl and 2,3-
pentanedione''
AGENCY: National Institute for Occupational Safety and Health (NIOSH),
Centers for Disease Control and Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of public meeting.
-----------------------------------------------------------------------
SUMMARY: The National Institute for Occupational Safety and Health
(NIOSH) of the Centers for Disease Control and Prevention (CDC) will
hold a public meeting to discuss and obtain comments on the draft
document, ``Criteria for a Recommended Standard: Occupational Exposure
to Diacetyl and 2,3-pentanedione''. A copy of the draft document will
be posted on the Internet at http://www.cdc.gov/niosh/docket/review/docket245/default.html for Docket number NIOSH-245 on August 12, 2011.
This notice serves as advance notice of the meeting and public comment
period.
Table of Contents
Date and Time
Address
Status
Speaker Registration
Agenda
Supplementary Information
I. Matters to Be Discussed
II. Transcripts
III. Public Comment Period
Contact Person for More Information
DATES and Time: August 26, 2011, 8 a.m.-4 p.m., Eastern Time. Please
note that public comments may end before the time indicated, following
the last call for comments. Members of the public who wish to provide
comments should plan to attend the meeting at the start time listed.
ADDRESSES: Omni Shoreham, 2500 Calvert, Street NW. (at Connecticut
Avenue) Washington, DC 20008.
Status: The meeting is open to the public limited only by the space
available. The meeting room accommodates 150 people. To pre-register
for the meeting, interested parties should contact the NIOSH Docket
Office at [email protected] or by fax at (513) 533-8285. Due to
limited space, notification of intent to attend the meeting must be
made to the NIOSH Docket Office no later than August 19, 2011. Priority
for attendance will be given to those providing oral comments. Other
requests to attend the meeting will then be accommodated on a first-
come basis.
Speaker Registration: Persons wanting to provide oral comments on
the draft document should contact the NIOSH Docket Office at
[email protected] or by fax at (513) 533-8285. Presenters will be
permitted approximately 10 minutes, and will be informed if additional
time becomes available. All requests to present should contain the
name, address, telephone number, and relevant business affiliations of
the presenter, and the topic of the presentation. Oral comments made at
the public meeting must also be submitted to the NIOSH Docket Office in
writing in order to be considered by the Agency.
Agenda: The meeting will begin with an introduction and
presentation by Federal officials, followed by presentations from
attendees who register to speak. Each speaker will be limited to ten
minutes. If all pre-registered presentations are complete before the
end time, there will be an open session to receive comments from anyone
who has not signed up on the speaker registration list who may wish to
speak. Open session comments will also be limited to 10 minutes per
speaker. After the last speaker or at 4 p.m., whichever occurs first,
the meeting will be adjourned.
SUPPLEMENTARY INFORMATION:
I. Matters To Be Discussed
At the public meeting, special emphasis will be placed on the
following topics:
1. Hazard identification, risk estimation, and discussion of health
effects for diacetyl and 2,3-pentanedione;
2. Basis of the Recommended Exposure Limit for diacetyl and 2,3-
pentanedione;
3. Workplaces and occupations where exposure to diacetyl and 2,3-
pentanedione occur;
4. Current exposure measurement methods;
5. Current strategies for controlling occupational exposure to
diacetyl and 2,3-pentanedione: e.g., engineering controls, work
practices, medical surveillance, and personal protective equipment;
6. Oral comments provided to NIOSH on the draft criteria document.
II. Transcripts
Transcripts will be prepared and posted to NIOSH Docket number 245
approximately 30 days after the meeting. If a person making a comment
gives his or her name, no attempt will be made to redact that name.
NIOSH will take reasonable steps to ensure that individuals making
public comments are aware of the fact that their comments (including
their name, if provided) will appear in a transcript of the meeting
posted on a public Web site. Such reasonable steps include: (a) A
statement read at the start of the meeting stating that transcripts
will be posted and names of speakers will not be redacted; and (b) A
printed copy of the statement mentioned in (a) above will be displayed
on the table where individuals sign up to make public comments. If
individuals in making a statement reveal personal information (e.g.,
medical information) about
[[Page 44339]]
themselves, that information will not usually be redacted. The CDC
Freedom of Information Act coordinator will, however, review such
revelations in accordance with the Freedom of Information Act and if
deemed appropriate, will redact such information. Disclosures of
information concerning third parties will be redacted.
III. Public Comment Period
Written comments on the document will be accepted until October 14,
2011 in accordance with the instructions below. All material submitted
to NIOSH should reference Docket Number NIOSH-245. All electronic
comments should be formatted as Microsoft Word or pdf files and make
reference to docket number NIOSH-245. To submit comments, please use
one of these options:
Present oral comments at the public meeting and provide a
written copy of comments to the NIOSH Docket Office.
Send NIOSH comments using the online form at http://www.cdc.gov/niosh/docket/review/docket245/comments.html.
Send comments by e-mail to
[email protected]?subject=245.
Facsimile: (513) 533-8285.
Mail: NIOSH Docket Office, Robert A. Taft Laboratories,
MS-C34 4676 Columbia Parkway, Cincinnati, Ohio 45226.
All information received in response to this notice will be
available for public examination and copying at, NIOSH Docket Office,
4676 Columbia Parkway, Room 111, Cincinnati, Ohio 45226. A complete
electronic docket containing all comments submitted will be available
on the NIOSH docket home page at http://www.cdc.gov/niosh/docket/, and
comments will be available in writing by request. NIOSH includes all
comments received without change in the docket, including any personal
information provided.
CONTACT PERSON FOR MORE INFORMATION: Lauralynn Taylor McKernan, ScD,
CIH, NIOSH, 4676 Columbia Parkway, MS-C32, Cincinnati, OH 45226,
telephone (513) 533-8542, fax (513) 533-8230, E-mail [email protected].
Dated: July 19, 2011.
John Howard,
Director, National Institute for Occupational Safety and Health,
Centers for Disease Control and Prevention.
[FR Doc. 2011-18755 Filed 7-22-11; 8:45 am]
BILLING CODE 4163-19-P